Cargando…
The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies
SIMPLE SUMMARY: Cannabinoids have been shown to suppress tumour cell proliferation, tumour invasion, metastasis, angiogenesis, chemoresistance and epithelial-mesenchymal transition and to induce tumour cell apoptosis, autophagy and immune response. This review focuses on the current status of invest...
Autores principales: | Ramer, Robert, Wittig, Felix, Hinz, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616499/ https://www.ncbi.nlm.nih.gov/pubmed/34830856 http://dx.doi.org/10.3390/cancers13225701 |
Ejemplares similares
-
Modulation of the Endocannabinoid System as a Potential Anticancer Strategy
por: Ramer, Robert, et al.
Publicado: (2019) -
Interleukin-1β Induces Tissue Factor Expression in A549 Cells via EGFR-Dependent and -Independent Mechanisms
por: Mechelke, Tobias, et al.
Publicado: (2021) -
Impact of Cannabinoid Compounds on Skin Cancer
por: Ramer, Robert, et al.
Publicado: (2022) -
Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
por: Ramer, Robert, et al.
Publicado: (2022) -
Antiangiogenic Action of JZL184 on Endothelial Cells via Inhibition of VEGF Expression in Hypoxic Lung Cancer Cells
por: Wittig, Felix, et al.
Publicado: (2023)